15.10.2017

Since April through September 2017, ARS registered a number of generic drugs (Montelukast, Nitrofurantoin, Tranexamic Acid, Torasemide, Dorzolamide, Iohexol, Clopidogrel, etc.) as well as successfully did several renewals (Simvastatin, Glucosamine + Chondroitin Sulphate + Vitamin E, Moxifloxacin, Lisinopril, Temozolomide, Piperacillin + Tazobactam, Clarithromycin, Ceftazidime, and Perindopril) for Indian, Pakistani, Russian, and UK pharmaceutical companies.